CD4+CD25(high), CD8+CD28- cells and thyroid autoantibodies in breast cancer patients.

Autor: Biylgi O; Department of Medical Oncology, GATA Haydarpasa Hospital, Istanbul, Turkey., Karagöz B; Department of Medical Oncology, GATA Haydarpasa Hospital, Istanbul, Turkey., Türken O; Department of Medical Oncology, Maltepe University, Istanbul, Turkey., Gültepe M; Department of Biochemistry, GATA Haydarpasa Hospital, Istanbul, Turkey., Özgün A; Department of Medical Oncology, GATA Haydarpasa Hospital, Istanbul, Turkey., Tunçel T; Department of Medical Oncology, GATA Haydarpasa Hospital, Istanbul, Turkey., Emirzeoğlu L; Department of Medical Oncology, GATA Haydarpasa Hospital, Istanbul, Turkey., Çelik S; Department of Medical Oncology, GATA Haydarpasa Hospital, Istanbul, Turkey., Müftüoğlu T; Department of Biochemistry, GATA Haydarpasa Hospital, Istanbul, Turkey., Gökhan Kandemir E; Department of Medical Oncology, Memorial Hospital, Istanbul, Turkey.

Publikováno v: Central-European journal of immunology [Cent Eur J Immunol] 2014; Vol. 39 (3), pp. 338-44. Date of Electronic Publication: 2014 Oct 14.